Mumbai’s KEM Hospital Plans AI Pilot for Brain Tumour and Epilepsy Diagnosis

Mumbai’s civic healthcare system is preparing to test artificial intelligence for the diagnosis and assessment of neurological disorders through a pilot project at KEM Hospital.

The proposed 12-month programme will involve 150 patients suffering from epilepsy and brain tumours. AI-based technology will analyse medical information from MRI and CT scans as well as electroencephalogram (EEG) recordings, helping doctors interpret complex neurological data more rapidly.

The technology is expected to assist clinicians in identifying the characteristics of brain tumours, detecting suspicious areas and locating possible focal points associated with epilepsy. It will also be used to assess changes in brain function before and after surgery.

Patients participating in the project will undergo follow-up assessments one, three and six months after surgical treatment. This will allow the medical team to examine whether AI can help monitor changes in brain activity and recovery over time, rather than limiting its role to initial diagnosis.

The project has been developed by BrainsightAI Technology and is estimated to cost approximately ₹4.99 crore. The proposal is to be presented for approval before the Standing Committee.

The initiative comes as hospitals across India increasingly explore artificial intelligence as a clinical decision-support tool. By processing large volumes of imaging, electrical and other medical data, such systems can assist doctors in recognising patterns that may require closer clinical investigation.

The technology, however, is intended to support rather than replace medical judgement. If the KEM Hospital pilot proves successful, the AI-based diagnostic facility could eventually be extended to other civic-run hospitals across Mumbai.

08-09-2026